Literature DB >> 326672

Possible dual function of M protein: resistance to bacteriophage A25 and resistance to phagocytosis by human leukocytes.

P P Cleary, Z Johnson.   

Abstract

Spontaneous phage A25-resistant (A25(R)) mutants of group A streptococci, strain K56, were isolated. The mutant cultures were unable to adsorb phage particles and hyperproduced M protein. Trypsin-digested A25(R) cells regained the ability to adsorb phage particles, but failed to become infectious centers. This failure indicated that the mutation created a double barrier to phage growth: (i) receptors were masked by M protein; (ii) irreversibly adsorbed phage were unable to multiply. Spontaneous variants of one A25(R) mutant, shown to be M negative (M(-)) by electron microscopy, serological tests, and sensitivity to phagocytosis, rapidly adsorbed phage and were able to become infectious centers. Therefore, it was concluded that the mutant phenotype, A25(R), arose by a single mutation and genes coding for this trait and M protein synthesis were either genetically linked, controlled by a common gene or were biochemically interdependent. The A25(R) phenotype was unstable and, as expected for plasmid-coded properties, acridine orange induced segregation of this phenotype. The parental M(+), A25-sensitive (A25(S)) cultures proved to be a mixed population. Infection at various multiplicities indicated that this culture was composed of phage A25(S) cells and cells more resistant to infection. Morphological comparison of thin sections of A25(R) and A25(S) cells by electron microscopy demonstrated striking differences. The A25(R) culture was composed entirely of cells uniformly covered with M protein, whereas the A25(S)M(+) wild-type culture was a mixed population, the majority of cells devoid of M protein. Phagocytosis by human blood enriched the culture for the latter cell type, suggesting that differences in phage sensitivity in the wild-type culture were also determined by the presence or absence of M protein. Thus M protein can serve a dual function for the streptococcal cell by allowing it to avoid infection by bacteriophage and ingestion by human leukocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326672      PMCID: PMC421520          DOI: 10.1128/iai.16.1.280-292.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  SYMPOSIUM ON RELATIONSHIP OF STRUCTURE OF MICROORGANISMS TO THEIR IMMUNOLOGICAL PROPERTIES. IV. ANTIGENIC AND BIOCHEMICAL COMPOSITION OF HEMOLYTIC STREPTOCOCCAL CELL WALLS.

Authors:  R M KRAUSE
Journal:  Bacteriol Rev       Date:  1963-12

2.  Chemical properties of streptococcal proteinase and its zymogen.

Authors:  T Y LIU; N P NEUMANN; S D ELLIOTT; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

3.  Laboratory diagnosis of streptococcal infections.

Authors:  R E WILLIAMS
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

4.  The influence of bacteriophage on Streptococcus pyogenes.

Authors:  W R MAXTED
Journal:  J Gen Microbiol       Date:  1955-06

5.  Studies on the biosynthesis of the M-protein of group A hemolytic streptococci.

Authors:  E N FOX; L O KRAMPITZ
Journal:  J Bacteriol       Date:  1956-04       Impact factor: 3.490

6.  Lysogenization and superinfection immunity in Salmonella.

Authors:  N D ZINDER
Journal:  Virology       Date:  1958-04       Impact factor: 3.616

7.  Enhancement of streptococcal bacteriophage lysis by hyaluronidase.

Authors:  W R MAXTED
Journal:  Nature       Date:  1952-12-13       Impact factor: 49.962

Review 8.  M proteins of group A streptococci.

Authors:  E N Fox
Journal:  Bacteriol Rev       Date:  1974-03

9.  Factors affecting the chain length of group A streptococci. II. Quantative M-anti-M relationships in the long chain test.

Authors:  R D EKSTEDT; G H STOLLERMAN
Journal:  J Exp Med       Date:  1960-10-01       Impact factor: 14.307

10.  FIBRINOGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. I. IDENTITY OF THE REACTANTS, AND STOICHIOMETRY OF THE REACTION.

Authors:  F S KANTOR
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

View more
  13 in total

1.  In vitro properties of a Listeria monocytogenes bacteriophage-resistant mutant predict its efficacy as a live oral vaccine strain.

Authors:  Patricia A Spears; M Mitsu Suyemoto; Terri S Hamrick; Rebecca L Wolf; Edward A Havell; Paul E Orndorff
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Discovery, purification, and characterization of a temperate transducing bacteriophage for Bordetella avium.

Authors:  C B Shelton; D R Crosslin; J L Casey; S Ng; L M Temple; P E Orndorff
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

3.  Purification and characterization of a hyaluronidase associated with a temperate bacteriophage of group A, type 49 streptococci.

Authors:  L C Benchetrit; E D Gray; R D Edstrom; L W Wannamaker
Journal:  J Bacteriol       Date:  1978-04       Impact factor: 3.490

4.  Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences.

Authors:  J C Robbins; J G Spanier; S J Jones; W J Simpson; P P Cleary
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

5.  Bacteriophage control of antiphagocytic determinants in group A streptococci.

Authors:  J G Spanier; P P Cleary
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

6.  Use of bacteriophage Ba1 to identify properties associated with Bordetella avium virulence.

Authors:  Celia B Shelton; Louise M Temple; Paul E Orndorff
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants.

Authors:  Bart J M Vlaminckx; Ellen M Mascini; Joop Schellekens; Leo M Schouls; Armand Paauw; Ad C Fluit; Rodger Novak; Jan Verhoef; Franz Josef Schmitz
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci.

Authors:  P P Cleary; A Larkin
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

9.  Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1981-08

10.  A Listeria monocytogenes mutant defective in bacteriophage attachment is attenuated in orally inoculated mice and impaired in enterocyte intracellular growth.

Authors:  Patricia A Spears; M Mitsu Suyemoto; Angela M Palermo; John R Horton; Terri S Hamrick; Edward A Havell; Paul E Orndorff
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.